Search filters

List of works by David Egilman

A commentary on Roggli's "The So-Called Short-Fiber Controversy"

scientific article

Commentary on "Assessment of Health Risk From Historical Use of Cosmetic Talcum Powder"

scientific article published on 19 August 2018

Guest authorship and ghostwriting in publications related to rofecoxib: a case study of industry documents from rofecoxib litigation

scientific article

Persistence of cardiovascular risk after rofecoxib discontinuation

scientific article

Pooled analysis of rofecoxib placebo-controlled clinical trial data: lessons for postmarket pharmaceutical safety surveillance

scientific article

Re: Regulatory Toxicology and Pharmacology

scientific article published in October 2003

Response to Hessel

scientific article published in October 2017

Response to Marsh, G. M., Ierardi, A. M., Benson, S. M., & Finley, B. L. (2019). Occupational exposures to cosmetic talc and risk of mesothelioma: an updated pooled cohort and statistical power analysis with consideration of latency period. Inhalati

scientific article published on 01 September 2019

Response to Paustenbach

scientific article published on 12 June 2019

Scientists appeal to Quebec Premier Charest to stop exporting asbestos to the developing world.

scientific article published in April 2010

Statement in Response to Asbestos Industry Efforts to Prevent a Ban on Asbestos in Pakistan:Chrysotile Asbestos Use is Not Safe and Must Be Banned

article

The Production of Corporate Research to Manufacture Doubt About the Health Hazards of Products: An Overview of the Exponent Bakelite® Simulation Study

scientific article published on 30 April 2018

Use of Anti-Warnings to Falsely Reassure Downstream Users: An Asbestos Example

scientific article published on 20 August 2018